Novel Immuno-oncology Therapy: Current Status of Clinical Research and Prospect of Application
10.3779/j.issn.1009-3419.2017.09.10
- VernacularTitle:新型免疫肿瘤治疗临床研究现状及应用前景
- Author:
ZHANG SHIJIA
1
;
REN SHENGXIANG
Author Information
1. 同济大学附属上海市肺科医院肿瘤科
- Keywords:
Neoplasms;
Immuno-oncology therapy;
Immune checkpoint inhibitor
- From:
Chinese Journal of Lung Cancer
2017;20(9):645-651
- CountryChina
- Language:Chinese
-
Abstract:
Recently,immune-oncologic therapy advanced rapidly and has been defined as another option,following surgery,radiotherapy,chemotherapy and molecular targeted therapy,for treatment of malignant diseases.To date,several immune checkpoint inhibitors and compounds have been approved to treat various of malignant diseases with efficiency.Meanwhile,more and more potential therapeutic targets in processes of the cancer immunity have been noticed.We aimed to summarize the research status and clinical prospects of novel immune-oncologic treatment agencies targeted to different steps of the cancer-immunity cycle.
